Emergent BioSolutions Inc. (EBS)

NYSE: EBS · IEX Real-Time Price · USD

11.20

-0.23 (-2.01%)

At close: Jul 19, 2024, 4:00 PM

11.10

-0.10 (-0.89%)

Pre-market: Jul 22, 2024, 7:37 AM EDT

Emergent BioSolutions Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2003
Revenue	1,185	1,049	1,118	1,774	1,577	1,106	Upgrade
Revenue Growth (YoY)	21.32%	-6.10%	-36.99%	12.45%	42.61%	41.36%	Upgrade
Cost of Revenue	697.1	705.4	693.1	748.1	537	433.5	Upgrade
Gross Profit	488.3	343.9	424.4	1,026	1,040	672.5	Upgrade
Selling, General & Admin	351.8	368.4	339.5	348.7	304.1	273.5	Upgrade
Research & Development	85.8	111.4	188.3	235.2	237.9	226.2	Upgrade
Other Operating Expenses	589.7	590.5	66.6	100.2	59.8	58.7	Upgrade
Operating Expenses	1,027	1,070	594.4	684.1	601.8	558.4	Upgrade
Operating Income	-539	-726.4	-170	341.4	438.5	114.1	Upgrade
Interest Expense / Income	94.3	87.9	37.3	34.5	31.3	38.4	Upgrade
Other Expense / Income	-74.8	-83.1	11.7	3.7	-4.7	-1.7	Upgrade
Pretax Income	-558.5	-731.2	-219	303.2	411.9	77.4	Upgrade
Income Tax	6.7	29.3	-7.4	83.7	106.1	22.9	Upgrade
Net Income	-565.2	-760.5	-211.6	219.5	305.8	54.5	Upgrade
Net Income Growth	-	-	-	-28.22%	461.10%	-13.08%	Upgrade
Shares Outstanding (Basic)	52	51	50	54	53	52	Upgrade
Shares Outstanding (Diluted)	52	51	50	54	54	52	Upgrade
Shares Change	3.98%	2.20%	-7.39%	0.56%	2.67%	1.95%	Upgrade
EPS (Basic)	-10.94	-14.85	-4.22	4.10	5.80	1.06	Upgrade
EPS (Diluted)	-10.94	-14.85	-4.22	4.06	5.68	1.04	Upgrade
EPS Growth	-	-	-	-28.52%	446.15%	-14.75%	Upgrade
Free Cash Flow	-132.2	-257.9	-149.9	96.1	395	101.1	Upgrade
Free Cash Flow Per Share	-2.53	-5.04	-2.99	1.80	7.50	1.96	Upgrade
Gross Margin	41.19%	32.77%	37.98%	57.82%	65.95%	60.80%	Upgrade
Operating Margin	-45.47%	-69.23%	-15.21%	19.25%	27.80%	10.32%	Upgrade
Profit Margin	-47.68%	-72.48%	-18.94%	12.38%	19.39%	4.93%	Upgrade
Free Cash Flow Margin	-11.15%	-24.58%	-13.41%	5.42%	25.04%	9.14%	Upgrade
Effective Tax Rate	-	-	-	27.61%	25.76%	29.59%	Upgrade
EBITDA	-345.8	-518.2	-38.4	461.5	557.7	226.5	Upgrade
EBITDA Margin	-29.17%	-49.39%	-3.44%	26.02%	35.36%	20.48%	Upgrade
Depreciation & Amortization	118.4	125.1	143.3	123.8	114.5	110.7	Upgrade
EBIT	-464.2	-643.3	-181.7	337.7	443.2	115.8	Upgrade
EBIT Margin	-39.16%	-61.31%	-16.26%	19.04%	28.10%	10.47%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).